Impact of af on sacubitril/valsartan dosing, persistance of treatment and associated outcomes in heart failure patients with reduced ejection fraction

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Acute heart failure - pharmacotherapy 2 Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by